| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 2K | $466K | $232.95 | 08 May 2025 | by Trust |
| Vir Biotechnology, Inc. | Director | Common Stock | 31.8K | $196K | $6.15 | 30 May 2025 | Direct |
| ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 775 | $181K | $232.95 | 08 May 2025 | Direct |
| Vir Biotechnology, Inc. | Director | Common Stock | 10K | $61.5K | $6.15 | 30 May 2025 | By Sigal Family Investments, LLC |
| Vir Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 16K | $24.5K | $1.53 | 30 May 2025 | Direct |
| Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 933K | 03 Jul 2023 | Direct | ||
| ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 1.56K | 08 May 2025 | Direct | ||
| Surface Oncology, Inc. | Director | Common Stock | 0 | $0.94 | 08 Sep 2023 | Indirect | |
| Surface Oncology, Inc. | Director | Stock Option (Right to Buy) | 0 | 08 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | 30 May 2025 | 2 | $0 | 4 | Director | 02 Jun 2025, 19:31 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 08 May 2025 | 2 | $0 | 4 | Director | 12 May 2025, 16:04 |
| VIR | Vir Biotechnology, Inc. | 30 May 2024 | 2 | $0 | 4 | Director | 03 Jun 2024, 12:18 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 16 May 2024 | 1 | $0 | 4 | Director | 20 May 2024, 16:08 |
| SURF | Surface Oncology, Inc. | 08 Sep 2023 | 2 | $0 | 4 | Director | 08 Sep 2023, 16:00 |
| ADAP | Adaptimmune Therapeutics PLC | 03 Jul 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 17:02 |
| VIR | Vir Biotechnology, Inc. | 22 May 2023 | 2 | $0 | 4 | Director | 24 May 2023, 14:33 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 18 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 16:06 |
| VIR | Vir Biotechnology, Inc. | 01 Mar 2023 | 1 | $56.8K | 4 | Director | 02 Mar 2023, 15:27 |
| VIR | Vir Biotechnology, Inc. | 05 Jan 2023 | 1 | $62.4K | 4 | Director | 09 Jan 2023, 10:51 |
| VIR | Vir Biotechnology, Inc. | 03 Jan 2023 | 2 | $127K | 4 | Director | 05 Jan 2023, 16:00 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 22 Aug 2022 | 1 | $0 | 4 | Director | 24 Aug 2022, 16:08 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 22 Aug 2022 | 0 | $0 | 3 | Director | 24 Aug 2022, 16:07 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 17:01 |
| SURF | Surface Oncology, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 20:00 |
| VIR | Vir Biotechnology, Inc. | 23 May 2022 | 2 | $0 | 4 | Director | 25 May 2022, 18:09 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 17:01 |
| SURF | Surface Oncology, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 16:30 |
| VIR | Vir Biotechnology, Inc. | 21 May 2021 | 2 | $0 | 4 | Director | 25 May 2021, 16:48 |